[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Martinello et al., 2012 - Google Patents

Comparison in vivo applications between peripheral blood-derived mesenchymal stromal cells (PB-MSCs) and platlet-rich plasma (PRP) in injured tendons of sheep

Martinello et al., 2012

Document ID
6772164969242788873
Author
Martinello T
Bronzini I
Perazzi A
Testoni S
DE BENEDICTIS G
Negro A
Caporale G
Mascarello F
Iacopetti I
Patruno M
et al.
Publication year
Publication venue
JOURNAL OF TISSUE SCIENCE & ENGINEERING

External Links

Snippet

Performance horses are most at risk of tendon injuries, degenerative tendinopathy and overuse tendinitis. Novel therapies aim to restore tendon functionality by means of cell- based therapy, growth factor delivery and tissue engineering approaches. This study …
Continue reading at www.research.unipd.it (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Similar Documents

Publication Publication Date Title
Galipeau et al. The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria
JP2015509360A5 (en)
ES2721180T3 (en) Therapeutic products using fat cells and cell secretions
HRP20150594T1 (en) Stromal stem cells
Meregalli et al. Mesenchymal stem cells as muscle reservoir
Martinello et al. Comparison in vivo applications between peripheral blood-derived mesenchymal stromal cells (PB-MSCs) and platlet-rich plasma (PRP) in injured tendons of sheep
Galderisi et al. Is it possible to improve the success rate of cellular therapy based on mesenchymal stem cells?
Patruno Regenerative strategies for different injuries of tendons: development of a biocompatible re-cellularized scaffold; in vivo treatment with MSCs and PRP in injured tendons
Patruno et al. In vivo regenerative strategies: use of adult stem cells and platlet-rich plasma in lesioned flexor tendons.
Ferreira et al. A pilot study: effect of autologous and allogeneic equine adipose-derived stem cells in musculoskeletal diseases
Svolacchia et al. Autologus Micrograft fat injection: microfiltration technique of disaggregated adipose tissue and skin regeneration. A clinical assessment study
Martinello et al. New regenerative strategies for tendon repair and regeneration.
Fagioli et al. Mesenchymal stem cells in Amyotrophic Lateral Sclerosis
Crovace et al. Survival of mesenchymal stem cells in collagenase induced tendonitis in an ovine model.
Clotilde et al. From cover to core: acellular human dermis for the regeneration of human heart
Capuco et al. In vivo treatment with xanthosine expands the mammary stem cell population
Gomiero et al. Treating skin wounds in Veterinary Medicine: conventional versus innovative therapies
Ferreira Gontijo De Amorim Histological and ultrastructural changes of human skin and subcutaneous layer after use of stromal vascular fraction-enriched fat and adipose-derived stem cells: Anti-aging treatment
Ferrario et al. The potential of innovative marine-derived biomaterials
Madonna Stem cells sources for cardiac regeneration: basic principles and route of delivery
Niada et al. Study of porcine adipose-derived stem cells for orthopaedic preclinical models
De Girolamo et al. Autologous and heterologous adipose derived stem cells seeded on oligo (polyethylene glycol) fumarate hydrogel scaffold are effective in the regeneration of critical osteochondral defects in minipig model
Maciotta Rolandin et al. Temporal monitoring of pO2 in stem cell cultures: a potential tool for directed differentiation
Arrigoni et al. Synthetic Bone Substitutes Differently Influence Human and Porcine Adipose-derived MSCs
Marmotti et al. One stage osteochondral repair with cartilage fragments in a hyaluronic acid/fibrin glue/platelet rich plasma scaffold: in vitro human and in vivo rabbit and goat animal model.